BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 32106841)

  • 1. Correction to: Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2020 Feb; 20(1):163. PubMed ID: 32106841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
    Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
    Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
    Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
    N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia.
    Sultana F; English DR; Simpson JA; Drennan KT; Mullins R; Brotherton JM; Wrede CD; Heley S; Saville M; Gertig DM
    Int J Cancer; 2016 Jul; 139(2):281-90. PubMed ID: 26850941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.
    Bartholomew K; Zhou L; Crengle S; Buswell E; Buckley A; Sandiford P
    BMC Public Health; 2019 Sep; 19(1):1245. PubMed ID: 31500594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials.
    Verdoodt F; Jentschke M; Hillemanns P; Racey CS; Snijders PJ; Arbyn M
    Eur J Cancer; 2015 Nov; 51(16):2375-85. PubMed ID: 26296294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's experience with home-based self-sampling for human papillomavirus testing.
    Sultana F; Mullins R; English DR; Simpson JA; Drennan KT; Heley S; Wrede CD; Brotherton JM; Saville M; Gertig DM
    BMC Cancer; 2015 Nov; 15():849. PubMed ID: 26536865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
    Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
    Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting.
    Sultana F; Mullins R; Murphy M; English DR; Simpson JA; Drennan KT; Heley S; Wrede CD; Brotherton JM; Saville M; Gertig DM
    Sex Health; 2015 Aug; 12(4):279-86. PubMed ID: 26028338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
    Virtanen A; Anttila A; Nieminen P
    BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
    Madzima TR; Vahabi M; Lofters A
    Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
    Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
    Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
    Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
    Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women.
    Zehbe I; Wakewich P; King AD; Morrisseau K; Tuck C
    BMJ Open; 2017 Sep; 7(8):e017384. PubMed ID: 28864487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.